Medtronic (MDT) Liabilities from Discontinued Operations (2017)
Medtronic's (MDT) quarterly Liabilities from Discontinued Operations came in at $893.0 million in Q3 2017, up 24.03% quarter-over-quarter from $720.0 million in Q2 2017.
Powered by 
Analysis
Medtronic (MDT) Liabilities from Discontinued Operations (2017) Analysis & Trends
Medtronic has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting $893.0 million for Q3 2017.
- In Q3 2017, Liabilities from Discontinued Operations changed N/A year-over-year to $893.0 million; the TTM figure through Jul 2017 stood at $893.0 million (changed N/A YoY), while the FY2017 annual figure was $720.0 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at $893.0 million for Q3 2017 at Medtronic, up from $720.0 million in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of $893.0 million in Q3 2017 to a low of $720.0 million in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.70 Bn | 18.30 Bn | 1.54 Bn |